Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Interest & Investment Income (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Interest & Investment Income for 3 consecutive years, with $710000.0 as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income rose 16.39% to $710000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Dec 2025, up 63.46% year-over-year, with the annual reading at $2.2 million for FY2025, 63.46% up from the prior year.
  • Interest & Investment Income hit $710000.0 in Q4 2025 for Camp4 Therapeutics, up from $423000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $710000.0 in Q4 2025 to a low of $94000.0 in Q3 2024.
  • Historically, Interest & Investment Income has averaged $476200.0 across 3 years, with a median of $511000.0 in 2023.
  • Biggest five-year swings in Interest & Investment Income: tumbled 86.36% in 2024 and later skyrocketed 350.0% in 2025.
  • Year by year, Interest & Investment Income stood at $569000.0 in 2023, then grew by 7.21% to $610000.0 in 2024, then increased by 16.39% to $710000.0 in 2025.
  • Business Quant data shows Interest & Investment Income for CAMP at $710000.0 in Q4 2025, $423000.0 in Q3 2025, and $453000.0 in Q2 2025.